Resources|Podcasts|March 28, 2025
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
Author(s)PPD, Thermo Fisher Scientific
As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
FDA Releases Draft Guidance on Registering Pharmaceuticals for Human Use
2
ACG Introduces SuperPod for Drug Protection and Sustainability
3
Integrating AI Discovery, Continuous Manufacturing, and Modern Regulatory Hurdles into Pharma Production
4
Pharmapack Europe 2026: Geopolitical Impacts on Pharmaceutical Packaging
5